Organogenesis
Manufacturing · Massachusetts, United States · 900 Employees
View Company Info for Free
About
Headquarters
150 Dan Rd, Canton, Massachusetts, 02021, Unite...Phone Number
(781) 575-0775Website
www.organogenesis.comRevenue
$448.4 MillionStock Symbol
ORGOIndustry
Most Recent Scoops
Project
Organogenesis is actively engaging with CMS to advocate for a value-based payment methodology for skin substitute products, which has the potential to reduce Medicare Part B expenditures, improve patient access, and enable physicians to prescribe treatments based on individual patient needs.
Earnings
reported $94.9 million in cash, cash equivalents and restricted cash, and $62.1 million in net debt obligations as of September 30, 2024, with up to $125 million of available borrowings on its revolving credit facility.
Highlights
$182.4M
Total Funding Amount
$100M
Most Recent Funding Amount
5
Number of Funding Rounds
Who is Organogenesis
Founded in 1985, Organogenesis is a retail and manufacturing of products for advanced wound care, and surgical and sports medicine markets, and regenerative medicine company. Organogenesis is located in Massachusetts.Explore more
Organogenesis Org Chart
Is Organogenesis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Organogenesis launches new products
Check out if Organogenesis is spiking on competitors!
Funding: Get notified immidiatlly once Organogenesis has new funding data
Check if Organogenesis has recently received funding, and reach out quickly before it becomes old news!
Click to see if Organogenesis had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Organogenesis
Website visits: Recent activity has been detected on your website
Organogenesis, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Organogenesis recently announced quarterly report
Recommended Actions
Find VP level buyers at Organogenesis
Find 2 more new buyers
Compare Similar Companies to Organogenesis
Compare insights from companies similar to Organogenesis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Organogenesis
$448.4M
900
Organogenesis financials insights
Gather financial insights about Organogenesis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Organogenesis Employee Growth Rate
View Organogenesis’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
Organogenesis Tech Stack
A closer look at the technologies used by Organogenesis
See more technologies
Most Recent Scoops
Project
Organogenesis is actively engaging with CMS to advocate for a value-based payment methodology for skin substitute products, which has the potential to reduce Medicare Part B expenditures, improve patient access, and enable physicians to prescribe treatments based on individual patient needs.
Business Development, Governmental Affairs & Regulation, Healthcare Operations, Operations, Regulations
Earnings
reported $94.9 million in cash, cash equivalents and restricted cash, and $62.1 million in net debt obligations as of September 30, 2024, with up to $125 million of available borrowings on its revolving credit facility.
Accounting, Financial Reporting, Business Finance, Finance
Project
submitted a comment letter to the MACs including high-quality published data evaluating NuShield, PuraPly AM, and NuShield for the treatment of DFUs and VLUs, demonstrating that these products meet the criteria for Medicare coverage under the proposed LCD.
Compliance, Search, Medical Research, Healthcare Operations, Operations
Project
Organogenesis announced additional clinical results from its first phase III clinical trial of 515 patients, meeting the primary endpoint of statistically significant reduction in knee pain and the first secondary endpoint of statistically significant maintenance of function at six months.
Search, Medical Research, Pharmaceuticals, Clinical Operations, Operations
Project
Search, Medical Research, Pharmaceuticals, Clinical Operations, Operations
Organogenesis News & Media
Organogenesis Expands Manufacturing Capacity to Support Future Growth
CANTON, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, announced plans to expand manufacturing capacity with a long-term lease for a 122,000-square foot state-of-the-art biomanufacturing facility located at 100 Technology Way in Smithfield, Rhode Island.Organogenesis Commends Final LCDs
Organogenesis Pleased to Lead Collaborative Effort to Support Data-Driven Policy on Local Coverage Determination Organogenesis Pleased to Lead Collaborative Effort to Support Data-Driven Policy on Local Coverage DeterminationOrganogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
CANTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for the third quarter ended September 30, 2024.Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock
Net proceeds to fund the Company’s strategic growth initiatives, enhance balance sheet flexibility, and finance privately negotiated stock repurchases Net proceeds to fund the Company’s strategic growth initiatives, enhance balance sheet flexibility, and finance privately negotiated stock repurchases
Read more news
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Organogenesis
Sign Up for FreeTo access detailed company insights
Founded in 1985, Organogenesis is a retail and manufacturing of products for advanced wound care, and surgical and sports medicine markets, and regenerative medicine company. Organogenesis is located in Massachusetts.... Read More
